Uploads from Me

Sunday, June 7, 2020

Can India attract China-wary oil majors?

To keep you updated, we send Daily Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here
THE ECONOMIC TIMESDaily Newsletter
Sun, Jun 07, 2020 | 06:11 PM IST
#Coronavirus#EconomyTracker#Whatsbuzzing
Top stories of the day
India's biggest asset sale could attract China-wary oil majors India's biggest asset sale could attract China-wary oil majors
Nations, including the US are coming together to counter China's growing threat to global trade....
Gross direct tax mop up dips 4.92% to Rs 12.33 lakh crore in FY20
No better time to bet on India than now, says billionaire Adani
BS-VI compliant vehicles to display green sticker
From rescue to recovery: Inside the fight for survival
Saudi Arabia's oil exports plunge $11 bn in 1st quarter
Pak sees highest inflation globally during 2020: SBP
Sebi bars Greencrest Financials, directors from capital markets for 3 years
Debate This
Can India do without China in a post-Covid world?
India has again found itself in an eyeball-to-eyeball confrontation with China. The new standoff comes at a time when India was hoping to make some inroads into Chinese dominance of global supply chains in a post-Covid world. But with its own domestic markets flooded with Chinese products, and a high dependency on Chinese imports to run its own factories, can India afford to antagonise its giant neighbour?

Top Gainers

NSE
24 companies (largecap) appreciated more than 5%
Tata Motors 12.44%
Tata Motors (dvr) 11.39%
More from Gainers

Top Losers

NSE
2 companies (largecap) price decreased more than -3%
SRF -3.89%
IGL -3.17%
More from Losers
More From our Partners
Meet woman bosses who are revolutionising start-up ecosystem
Reforming the pet-care industry in India and making citizens' voices heard on laws and regulations, Devanshi Shah and Antaraa Vasudev are revolutionising the start-up ecosystem.
AstraZeneca, Gilead talk fuels rumour of biggest healthcare deal on record AstraZeneca, Gilead talk fuels rumour of biggest healthcare deal on record
AstraZeneca, valued at $140 billion, is the U.K.'s biggest drugmaker by market capitalization and has developed treat...
Two-wheeler segment may see double digit sales dip this fiscal: HMSI
Sebi censures Astrazeneca Pharma's promoter, Elliot Group
Kotak tells banks how to survive the coming storm of defaults
Delhi to open its malls, restaurants and temples from tomorrow
China sticks to its guns, absolves itself of all Covid blame
Delhi lifts 'special corona fee' on liquor from June 10, but raises VAT
Can Saudi Arabia's Crown Prince fix his mistakes?
More From our Partners
This is how advertisers are engaging new-age users online

Follow Us on ET:
Facebook Twitter YouTube LinkedIn
About us|Advertise with us|Feedback|Sitemap|Code of Ethics
© 2020 Times Internet Limited.
To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today.
If you are having trouble viewing this newsletter, please click here
To unsubscribe or edit your subscriptions please click here

No comments:

Post a Comment